positivo73 schreef:
[quote=connect]
[quote=psycho-pharma]
Ook aardig van Yahoo:
Guidance: PPS btwn $12 - $24 for 2006!!
by: pix_with_x
Long-Term Sentiment: Strong Buy 03/03/06 06:54 am
Msg: 72524 of 72530
...Quick & dirty calculation
- No further dilution in 2006
- Cash position 25 mio, cashburn 45-48 mio, variance compensated by sales revenue!!
- Healthy Balance sheet; no suprises, no death bodies
- Outstanding shares are 78mio
- Market is around 30K kids
- Pricing (only for Iplex) estimated at $25k conservatively!
Revenue 2006: 6 months equals 0.5 year, is 30k * 25k * 0.5 = 375 mio Revenue
Revenue / share equals $4.81
Bio-multiplicator: 2.5
PPS for 2006 is at a minimum: $4.81 * 2.5 = $12.00
This is the guidance for 2006, only taking into account the commercial launch and success of Iplex. Not taking into account are any expectation towards developements & FDA approval concerning Diabetes I / II trials or revenues coming from:
1. Recombinant human insulin-like growth factor-I/insulin-like growth factor binding protein-3 for Treatment of major burns that require hospitalization.
2. rhIGF-I/rhIGFBP-3 for Treatment of extreme insulin resistance syndromes (type A, Rabson-Mendenhall syndrome, Leprechaunism, Type B syndrome)
3. mecasermin rinfabate for Treatment of growth hormone insensitivity syndrome (GHIS)
...So as you can see, it's a conservative guidance, in line with the one MIDDLETON & CO gave last night!
...If you do your DD, you will draw the same conclusion!!
Ch, S.
Psycho
nog even op zoek naar Middleton & Co
[/quote]
revenue 2006 375 miljoen, dat gelooft toch niemand hier he
[/quote]
Mij verbaasd niks meer, het kan zomaar gebeuren. Ik denk namelijk dat de koers als die eenmaal begint op te lopen als voorbeeld Crucell zal nemen.
m.v.g.Willem